> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-21/
- Published: 2020-10-25T12:00:00.000Z
- Updated: 2026-09-14T16:33:54.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146712

[**Guide on Nicotine Delivery System Enforcement**](https://www.fdaweb.com/guide-on-nicotine-delivery-system-enforcement/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Enforcement Priorities for Electronic Nicotine Delivery Systems (ENDS) and Other Deemed Products on the Market Without Premarket Authorization (Revised).” 10/23/2020

[**Info Collection on Animal Drugs for Minor Species**](https://www.fdaweb.com/info-collection-on-animal-drugs-for-minor-species/)  
*Federal Register* notice: FDA sends to OMB an information collection extension for “Index of Legally Marketed Unapproved New Animal Drugs for Minor Species — 21 CFR Part 516.” 10/22/2020

[**Device Conformity Assessment Pilot Info**](https://www.fdaweb.com/device-conformity-assessment-pilot-info/)  
*Federal Register* notice: FDA sends to OMB a new information collection entitled “Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program.” 10/22/2020  
  
[**Nonclinical Study Data eSubmission Pilot**](https://www.fdaweb.com/nonclinical-study-data-esubmission-pilot/)  
*Federal Register* notice: FDA announces that it intends to conduct a fit-for-use pilot program to test the processing and analysis of nonclinical study data submitted electronically. 10/22/2020

[**28 Drugs Not Withdrawn Due to Safety/Efficacy**](https://www.fdaweb.com/28-drugs-not-withdrawn-due-to-safety-efficacy/)  
*Federal Register* notice: FDA determines that 28 drug products listed in the notice were not withdrawn from sale for safety or effectiveness reasons. 10/21/2020